<DOC>
	<DOCNO>NCT02245555</DOCNO>
	<brief_summary>Study describe Tamsulosin prescription characteristic representative population patient treatment benign prostatic hyperplasia</brief_summary>
	<brief_title>Observational Study Tamsulosin Patients With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients older 21 year old diagnose benign prostatic hyperplasia ( BPH ) , require pharmacological treatment relieve symptom improve quality life , accord physician 's judgment . The study include na√Øve patient patient respond previous therapy receive Secotex alternative complementary treatment . The decision treat patient Tamsulosin must base best standard accept clinical practice must carry follow Secotex ( Tamsulosin ) prescription information Patients know hypersensitivity Tamsulosin ingredient , history orthostatic hypotension severe liver failure , miss data require complete questionnaire exclude</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>